Literature DB >> 34654892

Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Pushpinder Kanda1,2, Arnav Gupta3, Chloe Gottlieb4,5,6, Rustum Karanjia4,5,6,7,8, Stuart G Coupland4,5,3, Manpartap Singh Bal9.   

Abstract

The pathogenesis of central serous chorioretinopathy (CSCR), a pachychoroid disease, is poorly understood. While choroid hyperpermeability and retinal pigment epithelium dysfunction are cornerstones for developing CSCR, the mechanisms at the retinal, vascular, retinal pigment epithelium, and cellular level continue to be an enigma. A few preclinical studies and the development of small-sized, poorly controlled clinical trials have resulted in limited insight into the disease mechanism. Effective treatments for CSCR are still lacking as current trials have produced inconsistent results for functional and structural gains. Thus, critically evaluating the literature to explore disease mechanisms and provide an up-to-date understanding of pathophysiology can provide valuable information and avenues to new treatments. In this study, a comprehensive summary of the mechanistic insight into CSCR is presented while highlighting the shortcomings of current literature. The mechanism was divided into seven sub-categories including mechanical obstruction, inflammation, oxidative stress, paracrine factors, autonomic dysfunction, mineralocorticoid receptors activation, and medications. We implemented validated tools like the JBI and CAMARADES to objectively analyze the quality of both clinical and preclinical studies, respectively. Overall, our analysis of the literature showed that no single mechanism was populated with a large number of sufficiently sized and good-quality studies. However, compiling these studies gave hints not only to CSCR pathogenesis but also pachychoroid disease in general while providing suggestions for future exploration.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2021        PMID: 34654892      PMCID: PMC9046392          DOI: 10.1038/s41433-021-01808-3

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  118 in total

Review 1.  Central serous chorioretinopathy following oral tadalafil.

Authors:  P Gordon-Bennett; T Rimmer
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

2.  Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.

Authors:  Lihong Yang; Jost B Jonas; Wenbin Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-12       Impact factor: 4.799

3.  A novel marker in acute central serous chorioretinopathy: thiol/disulfide homeostasis.

Authors:  Hasan Altinkaynak; Piraye Zeynep Kurkcuoglu; Mehtap Caglayan; Mücella Arıkan Yorgun; Nilay Yuksel; Pınar Kosekahya; Cemile Koca; Yasin Toklu
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

4.  The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy.

Authors:  Ji Won Lim; Su Jeong Ryu; Min Cheol Shin
Journal:  Korean J Ophthalmol       Date:  2010-06-05

5.  Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy.

Authors:  Femke M van Haalen; Elon H C van Dijk; Cornelie D Andela; Greet Dijkman; Nienke R Biermasz; Alberto M Pereira; Camiel J F Boon
Journal:  Acta Ophthalmol       Date:  2018-10-30       Impact factor: 3.761

6.  Retinal detachment model in rodents by subretinal injection of sodium hyaluronate.

Authors:  Hidetaka Matsumoto; Joan W Miller; Demetrios G Vavvas
Journal:  J Vis Exp       Date:  2013-09-11       Impact factor: 1.355

Review 7.  Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress.

Authors:  Jereme G Spiers; Hsiao-Jou Cortina Chen; Conrad Sernia; Nickolas A Lavidis
Journal:  Front Neurosci       Date:  2015-01-19       Impact factor: 4.677

8.  Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.

Authors:  Shoji Kishi; Hidetaka Matsumoto; Shozo Sonoda; Takashi Hiroe; Taiji Sakamoto; Hideo Akiyama
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

9.  Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study.

Authors:  Fabio Mazzolani; Stefano Togni
Journal:  Clin Ophthalmol       Date:  2013-05-22

10.  Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment.

Authors:  Pradeep Venkatesh; Rohan Chawla; Koushik Tripathy; Harsh Inder Singh; Ravi Bypareddy
Journal:  Eye Vis (Lond)       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.